Pfizer Inc.

Follow

This company has no active jobs

0 Review

Rate This Company ( No reviews yet )

Work/Life Balance
Comp & Benefits
Senior Management
Culture & Value

Pfizer Inc.

(0)

About Us

Erectile Dysfunction Drugs could Assist Treat Oesophageal Cancer, Study Finds

Erectile dysfunction drugs could assist treat oesophageal cancer, research study discovers

22 June 2022

An active ingredient in impotence medication might help treat oesophageal cancer, a study has actually found.

Southampton researchers found the PDE5 inhibitors in the medication helped penetrate the barrier of cells around tumours, making it possible for chemotherapy drugs to reach cancer cells.

One in 10 clients currently makes it through the disease, which is discovered anywhere in the gullet, for 10 years or more.

The study was moneyed by Cancer Research UK. The next stage is a clinical trial.

Prof Tim Underwood, lead author of the research study, stated the discovery might enhance these survival rates.

He stated a cell called the cancer-associated fibroblast, accountable for wound healing, might be targeted with the inhibitors.

“It’s been utilized throughout the world in countless doses,” he described. “It’s safe, and we used it to cancer.”

He added it was to the researchers “amazement and surprise and delight” that the drug had a result.

“We need to put this into a clinical trial where we attempt the drug type together with chemotherapy to see if it makes the chemotherapy more reliable,” he stated.

“The initial work suggests it must do, and if it does and if it’s safe, and it enhances outcomes of chemotherapy, then it could be truly considerable for the patients I care for.”

The study was carried out using tumours from 8 cancer patients, with further tests done on mice.

Chemotherapy only assists 20% of oesophageal cancer clients in a significant method, he said.

“If this drug mix even enhances it by a small quantity, we’re really going to assist a large number of people every year to respond better and live longer.”

Researchers at Southampton University Hospitals state that the usual results of erectile dysfunction disorder drugs require additional stimulation, so would not affect cancer in the same way.

Prof Underwood said the main side results would be “a little headache, a little flushing”.

Terry Daly, from Aldershot, Hampshire, is one of the 9,500 people detected with oesophageal cancer in the UK every year.

It often goes undetected in the early phases, with Mr Daly discovering it was hard to swallow his food and he ended up regurgitating it.

He is shortly to go through another round of chemotherapy, and stated if he had the alternative to take the new treatment he would have “taken it with both hands”.

“The research that is being done is absolutely great,” he said.

“It is simply incredible that there are individuals out there ready to invest their lives just looking for a cure, so that individuals can get on with their everyday lives and not need to go through all this stuff.

“You can’t thank these people enough for what they’re doing.”

The five-year study has been moneyed by Cancer Research UK and the Medical Research Council.

A scientific trial is anticipated within the next 18 months and if effective, it is hoped new treatments based upon this research could be used within ten years.

Follow BBC South on Facebook, external, Twitter, external, or Instagram, external. Send your story ideas to south.newsonline@bbc.co.uk, external.

Related topics

Aldershot

Southampton

Cancer

We had the very same cancer as Andy Goram

31 May 2022

Lorry motorist’s ‘ticking time-bomb’ cancer gene

20 June 2022

Related internet links

Cancer Research UK

University Hospital Southampton

Institute of Developmental Sciences – University of Southampton

What is oesophageal cancer? – NHS

The BBC is not responsible for the material of external sites.